FDA awards Argenica two key designations for drug candidate targeting infant brain injury
Argenica Therapeutics Ltd (ASX:AGN) has seen its share price rise nearly 5%…
Argenica Therapeutics Limited (ASX:AGN)
About Argenica Therapeutics Limited
Key Information
AGN In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 13/11/2024 | Final Director's Interest Notice | 228.49KB | 228 |
| 13/11/2024 | AGM Chair's Address & MD Presentation | 3.83MB | 562 |
| 13/11/2024 | Results of Annual General Meeting | 248.62KB | 156 |
| 01/11/2024 | Price Sensitive PS Positive DSMB Safety Outcome & Phase 2 Trial Progress Update | 306.15KB | 5.2K |
| 31/10/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report - updated | 384.62KB | 282 |
| 31/10/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 377.84KB | 722 |
| 30/10/2024 | Price Sensitive PS FDA Grants ODD & RPDD for Second Drug in Treatment of HIE | 281.27KB | 21K |
| 29/10/2024 | Investor Presentation | 2.77MB | 1.2K |